US 7381744
Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
granted A61KA61K31/357A61K31/365
Quick answer
US patent 7381744 (Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/357, A61K31/365, A61K31/366, A61K31/39